Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Developing microbeam radiation therapy (MRT) for inoperable cancer

13.05.2020

An innovative radiation treatment that could one day be a valuable addition to conventional radiation therapy for inoperable brain and spinal tumors is a step closer, thanks to new research led by University of Saskatchewan (USask) researchers at the Canadian Light Source (CLS).

Microbeam radiation therapy (MRT) uses very high dose, synchrotron-generated X-ray beams--narrower than a human hair--to blast tumours with radiation while sparing healthy tissue.


USask PhD bio-medical engineering student Farley Chicilo at the Canadian Light Source synchrotron at University of Saskatchewan.

Credit: Canadian Light Source, University of Saskatchewan

Usage Restrictions: Only to be used in conjunction with this story, and with appropriate credit.

The idea is that MRT would deliver an additional dose of radiation to a tumor after maximum conventional radiation therapy has been tried, thereby providing patients with another treatment that could extend their lives.

But the longstanding questions have been: What is the optimal X-ray energy range of the MRT radiation dose that will both penetrate the thickness of the human body and still spare the healthy cells? How can the extremely high radiation doses be delivered and measured with the accuracy necessary for human treatment?

In a just-published paper in Physics in Medicine and Biology, the research team is the first to show that MRT can be scaled up for human radiation treatment. The team has identified how the radiation can be optimally delivered to ensure the safety and effectiveness of the potential human cancer treatment.

"The challenge has been to determine the ideal energy range needed so that the therapy can be used in humans with the next generation of synchrotrons," said Farley Chicilo, a USask PhD student in bio-medical engineering and lead author of the paper.

The energy range that's available now at synchrotrons around the world is not sufficient to penetrate the thickness of the human body.

"We were able to identify the higher X-ray energy range needed to penetrate the thickness of the human body, validating predictions from mathematical modeling," said Chicilo, noting that mathematical modeling had indicated the optimal X-ray energy would be 150 to 250 kiloelectron volts (keV).

MRT has a key advantage over other types of radiation: because the microscopically narrow beam of bombarding X-rays is sectioned like the teeth on a comb, the unirradiated healthy tissue in the spaces between the fine microbeams is able to help heal the irradiated tissue in the microbeam path.

"For MRT to be successful, we need the parallel microbeams to be as sharply defined as possible," Chicilo said. "Imagine a tumour therapy using knife cuts so thin that they could cut completely through an animal's spinal cord, and not paralyze the animal. MRT is that thin knife cut."

The team's experiment showed that at 150 keV, the high-energy, high-intensity microbeams were not blurred, allowing the damaged cells in the microbeam path to be quickly repaired by adjacent healthy cells.

"One might think that at higher energy the electrons would scatter more and damage surrounding tissue but it's the opposite," said USask medical imaging expert Dean Chapman, Chicilo's co-supervisor. "This new knowledge will affect how dedicated machines for MRT will be developed in future."

Another significant challenge for scientists investigating MRT has been the lack of a detector that can accurately and precisely measure the extremely high radiation doses at micron scale resolution.

"What our team did was to develop a unique high-dose radiation measurement detector technique and use it to determine the exact radiation dose contour delivered by the microbeam," said USask engineering professor Safa Kasap, who has been working on X-ray imaging detectors for more than two decades and is Chicilo's supervisor.

The detector uses a special glass containing samarium, a rare Earth ion, that helped the team measure the radiation dose and ensure it is precise and controlled. The glass itself was prepared by Andy Edgar at the Victoria University of Wellington in New Zealand, a long-time collaborator of the USask group. The detector using this glass and the measurement apparatus were designed and developed at USask, the only place that uses this unique material for MRT measurement of ionizing radiation.

Samarium glows orange when excited by a blue laser, but when exposed to X-rays, the ions gain an electron and glow red. By observing the ratio of orange to red light, the team was able to measure the dose deposited at a very high resolution over the large dose range of MRT.

"This is one of the best detectors that has been developed for measuring the detailed contour of the edges of the microbeam," said Kasap.

The new-found ability to predict both an ideal energy range of X-rays and the ideal width of the microbeams for human therapy will be "critical in future for treatment planning in clinical trials," said USask adjunct professor and team member Dr. Fred Geisler, a nuclear physicist and neurosurgeon who is an internationally renowned expert in spinal cord injury and spinal surgery.

"These are important and exciting steps in a process to make MRT available for human cancer treatment," Geisler said, adding this could take a decade.

Synchrotrons are the only means of generating high enough strength of parallel X-rays for MRT research. The CLS is one of only a few facilities in the world that can produce microbeams with the appropriate energy range for testing biological and medical applications.

Having the CLS located on the USask campus along with the Western College of Veterinary Medicine and the Saskatchewan Cancer Agency (SCA) creates a critical mass of multi-disciplinary researchers to continue to advance MRT.

In fact, Chicilo and some of his co-authors are currently working with the SCA on a mouse model to determine when to perform MRT after standard radiation therapy has already been tried.

###

The research team also involves USask adjunct professor Al Hanson, George Belev of the University's Saskatchewan Structural Sciences Centre, and former USask engineering graduate student Kieran Ramaswami.

The research was funded by the Natural Sciences and Engineering Research Council of Canada.

Media Contact

Victoria Schramm
victoria.schramm@lightsource.ca
306-657-3516

http://www.usask.ca 

Victoria Schramm | EurekAlert!
Further information:
http://dx.doi.org/10.1088/1361-6560/ab7361

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Technology innovation for neurology: Brain signal measurement using printed tattoo electrodes

TU Graz researcher Francesco Greco has developed ultra-light tattoo electrodes that are hardly noticeable on the skin and make long-term measurements of brain activity cheaper and easier.

In 2015 Francesco Greco, head of the Laboratory of Applied Materials for Printed and Soft electronics (LAMPSe, http://lampselab.com/) at the Institute of Solid...

Im Focus: Future information technologies: 3D Quantum Spin Liquid revealed

Quantum Spin Liquids are candidates for potential use in future information technologies. So far, Quantum Spin Liquids have usually only been found in one or two dimensional magnetic systems only. Now an international team led by HZB scientists has investigated crystals of PbCuTe2O6 with neutron experiments at ISIS, NIST and ILL. They found spin liquid behaviour in 3D, due to a so called hyper hyperkagome lattice. The experimental data fit extremely well to theoretical simulations also done at HZB.

IT devices today are based on electronic processes in semiconductors. The next real breakthrough could be to exploit other quantum phenomena, for example...

Im Focus: IST Austria scientists demonstrate quantum radar prototype

Physicists at the Institute of Science and Technology Austria (IST Austria) have invented a new radar prototype that utilizes quantum entanglement as a method of object detection. This successful integration of quantum mechanics into our everyday devices could significantly impact the biomedical and security industries. The research is published in the journal Science Advances.

Quantum entanglement is a physical phenomenon where two particles remain inter-connected, sharing physical traits regardless of how far apart they are from one...

Im Focus: First simulation of a full-sized mitochondrial membrane

New algorithm links different scales, bringing simulated cell a step closer

Scientists from the University of Groningen have developed a method that combines different resolution levels in a computer simulation of biological membranes.

Im Focus: How Nano-Sensors Help with Treatment

ESF-funded project "SenseCare” at Chemnitz University of Technology successfully completed - Therapeutic support, especially for diabetes mellitus

In the medical field, flexible and highly sensitive sensors can combine diagnostics and treatment with high comfort for patients.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

13th AKL – International Laser Technology Congress: May 4–6, 2022 in Aachen – Laser Technology Live already this year!

02.04.2020 | Event News

 
Latest News

Platelets exacerbate immune response

13.05.2020 | Life Sciences

Oink, oink makes the pig - Pictures and gestures are effective support methods in foreign language teaching for children

13.05.2020 | Science Education

Noble Metal Aerogels Enabled by Freezing: Multi-Scale Structured Materials for Electrocataly­sis and Photoelectro­catalysis

13.05.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>